Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
The Journal of Rheumatology
|
October 13, 2009
Outcome domains for studies of acute and chronic gout
H Ralph Schumacher, William Taylor, Lawrence Edwards, et al.
Arthritis Research & Therapy
|
July 20, 2014
Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis
Carlos Zamora-Atenza, Cesar Diaz-Torne, Carme Geli, et al.
Seminars in Arthritis and Rheumatism
|
November 22, 2017
The combination of IL-6 and its soluble receptor is associated with the response of rheumatoid arthritis patients to tocilizumab
Cesar Diaz-Torne, Maria Dels Angels Ortiz, Patricia Moya, et al.
The Journal of Rheumatology
|
October 13, 2009
Progress in measurement instruments for acute and chronic gout studies
Rebecca Grainger, William J Taylor, Nicola Dalbeth, et al.
Rheumatology International
|
January 27, 2020
A treat-to-target approach for gout confers renoprotective effect in patients with chronic kidney disease stage 3
Marta Novella-Navarro, Jose Luis Cabrera-Alarcon, Cesar Diaz-Torne, et al.
Frontiers in Immunology
|
March 12, 2024
Prognostic significance of lymphocytic foci composition in minor salivary gland biopsies for severe disease flare and severity in Sjögren's syndrome: a 3-year follow-up cohort study
Hye-Sang Park, Laura Martínez-Martínez, Berta Magallares López, et al.
Seminars in Arthritis and Rheumatism
|
March 24, 2023
Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome set
Melanie B Morillon, Alexander Nørup, Jasvinder A Singh, et al.
Seminars in Arthritis and Rheumatism
|
June 12, 2026
The OMERACT core domain sets for calcium pyrophosphate deposition disease
Nicola Dalbeth, Yiling Zhang, Owen Hensey, et al.
Seminars in Arthritis and Rheumatism
|
June 18, 2021
Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group
Ken Cai, Amy Fuller, Yiling Zhang, et al.
Seminars in Arthritis and Rheumatism
|
March 14, 2025
Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensus
Yiling Zhang, Sara K Tedeschi, Abhishek Abhishek, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
The Journal of Rheumatology
|
October 13, 2009
Outcome domains for studies of acute and chronic gout
H Ralph Schumacher, William Taylor, Lawrence Edwards, et al.
Arthritis Research & Therapy
|
July 20, 2014
Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis
Carlos Zamora-Atenza, Cesar Diaz-Torne, Carme Geli, et al.
Seminars in Arthritis and Rheumatism
|
November 22, 2017
The combination of IL-6 and its soluble receptor is associated with the response of rheumatoid arthritis patients to tocilizumab
Cesar Diaz-Torne, Maria Dels Angels Ortiz, Patricia Moya, et al.
The Journal of Rheumatology
|
October 13, 2009
Progress in measurement instruments for acute and chronic gout studies
Rebecca Grainger, William J Taylor, Nicola Dalbeth, et al.
Rheumatology International
|
January 27, 2020
A treat-to-target approach for gout confers renoprotective effect in patients with chronic kidney disease stage 3
Marta Novella-Navarro, Jose Luis Cabrera-Alarcon, Cesar Diaz-Torne, et al.
Frontiers in Immunology
|
March 12, 2024
Prognostic significance of lymphocytic foci composition in minor salivary gland biopsies for severe disease flare and severity in Sjögren's syndrome: a 3-year follow-up cohort study
Hye-Sang Park, Laura Martínez-Martínez, Berta Magallares López, et al.
Seminars in Arthritis and Rheumatism
|
March 24, 2023
Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome set
Melanie B Morillon, Alexander Nørup, Jasvinder A Singh, et al.
Seminars in Arthritis and Rheumatism
|
June 12, 2026
The OMERACT core domain sets for calcium pyrophosphate deposition disease
Nicola Dalbeth, Yiling Zhang, Owen Hensey, et al.
Seminars in Arthritis and Rheumatism
|
June 18, 2021
Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group
Ken Cai, Amy Fuller, Yiling Zhang, et al.
Seminars in Arthritis and Rheumatism
|
March 14, 2025
Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensus
Yiling Zhang, Sara K Tedeschi, Abhishek Abhishek, et al.
Page
of 5